Infants Will Be Able to Receive an RSV Shot This Fall
Very Well Health
Published on July 25, 2023
Key Takeaways
- The FDA has approved the first RSV shot for infants, which should prevent thousands of hospitalizations each year.
- The immunization, called Beyfortus, is manufactured by Sanofi and AstraZeneca.
- Beyfortus is intended to be administered within the first five months of life, but can also be given to children up to 2 years old.
- A maternal RSV vaccine is also in development by Pfizer.
https://www.verywellhealth.com/infant-rsv-vaccine-approved-7555126